Battelle Expanding in the U.K.
Global R&D organization Battelle has begun construction of an advanced research-and-development facility in Chelmsford, U.K., that will expand its global footprint and capacity to provide advanced science and technology solutions for the agriculture, food and health care industries.
The new, 20,327-sq.-ft. (1,888-sq.-m.) facility at Chelmsford Business Park is an expansion of Battelle's existing operations in the United Kingdom and will open in April 2013. The new facility will augment Battelle's established global scientific expertise in formulation development, toxicology and biotechnology programs that help agriculture and food customers accelerate product development and meet multi-national regulatory requirements. It also opens additional opportunities to serve the research and development needs for pharmaceutical, medical device and other health and life science companies across Europe and around the world.
Global healthcare product company Covidien has opened four new R&D centers in the U.S., France and India. The Massachusetts-based company has invested more than $40 million in the facilities.
Pharmaceutical services firm Almac is expanding its U.S. presence with a new packaging operation in Pennsylvania. The company expects to open the facility this fall.
Israel Announces New Life Science Incentives
The Office of the Chief Scientist (OCS) at the Israeli Ministry of Industry, Trade and Labor launched two new programs to help promote foreign investment in Israeli R&D in the life sciences sector.
Under the first initiative, international corporations will commit to establishing an R&D center in Israel that will employ more than 60 workers for a period of no less than 5 years. R&D centers established in the center of the country will receive government support of about 19 million shekels (US$5.1 million), whereas R&D centers set up in Israel's periphery in the north or south will receive about 32 million shekels ($8.6 million).
Under the second initiative, international corporations invest no less than $20 million in projects by Israeli companies in the life sciences sector over the course of five years. The OCS will then offer support of up to 50 percent of the projects. The corporations will also be required to contribute to R&D activity through professional guidance, managerial advice and exposure to knowledge and work methods at the international corporation.
BASF is investing $33 million in plant biotechnology and crop protection research at its facilities in North Carolina's Research Triangle Park.
Biomerics, a supplier of plastic products for the medical device and healthcare sectors, has expanded its manufacturing operations in Salt Lake City.
VGTI Florida Opens New Facility
The Tradition Center for Innovation (TCI) and the Vaccine & Gene Therapy Institute (VGTI) Florida today announced the opening of a new, 100,000-sq.-ft. (9,290-sq.-m.) facility within TCI's 150-acre (61-hectare) research park located in the planned community of Tradition in Port St. Lucie, Fla. Since breaking ground in 2006, TCI has attracted top research institutes and healthcare facilities making it one of the fastest growing immunology research hubs in the country.
"Having the opportunity to expand our portfolio and work alongside leading institutes, such as Torrey Pines, solidified our decision to expand to Florida and house our new facility at TCI," said VGTI CEO Mel Rothberg. "We are thankful for the support from our fellow anchor members at TCI and the city of Port St. Lucie and look forward to being a part of the community."
Since TCI's first anchor member, the Torrey Pines Institute for Molecular Studies, expanded its San Diego-based facility to Tradition in 2006, TCI has brought an estimated 170 new jobs to the community and created an estimated 1,000 construction jobs. In addition, business service companies that provide life science products such as cylinder gas, biological reagents, gowning, IT, office furniture, scientific equipment and others, have all seen tremendous increases in sales.